{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:48:03Z","timestamp":1770817683956,"version":"3.50.1"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271-CRC\/TRR205"],"award-info":[{"award-number":["314061271-CRC\/TRR205"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017659","name":"Uniscientia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Adrenocortical carcinoma (ACC) is a rare endocrine malignancy and treatment of advanced disease is challenging. Clinical trials with multi-tyrosine kinase inhibitors in the past have yielded disappointing results. Here, we investigated fibroblast growth factor (FGF) receptors and their pathways in adrenocortical tumors as potential treatment targets. We performed real-time RT-PCR of 93 FGF pathway related genes in a cohort of 39 fresh frozen benign and malignant adrenocortical, 9 non-adrenal tissues and 4 cell lines. The expression of FGF receptors was validated in 166 formalin-fixed paraffin embedded (FFPE) tissues using RNA <jats:italic>in situ<\/jats:italic> hybridization (RNAscope) and correlated with clinical data. In malignant compared to benign adrenal tumors, we found significant differences in the expression of 16\/94 FGF receptor pathway related genes. Genes involved in tissue differentiation and metastatic spread through epithelial to mesechymal transition were most strongly altered. The therapeutically targetable FGF receptors 1 and 4 were upregulated 4.6- and 6-fold, respectively, in malignant compared to benign adrenocortical tumors, which was confirmed by RNAscope in FFPE samples. High expression of FGFR1 and 4 was significantly associated with worse patient prognosis in univariate analysis. After multivariate adjustment for the known prognostic factors Ki-67 and ENSAT tumor stage, FGFR1 remained significantly associated with recurrence-free survival (HR=6.10, 95%CI: 1.78 \u2013 20.86, p=0.004) and FGFR4 with overall survival (HR=3.23, 95%CI: 1.52 \u2013 6.88, p=0.002). Collectively, our study supports a role of FGF pathways in malignant adrenocortical tumors. Quantification of FGF receptors may enable a stratification of ACC for the use of FGFR inhibitors in future clinical trials.<\/jats:p>","DOI":"10.3389\/fendo.2021.795116","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T10:49:34Z","timestamp":1639046974000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications"],"prefix":"10.3389","volume":"12","author":[{"given":"Iuliu","family":"Sbiera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constanze","family":"Hantel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silviu","family":"Sbiera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Kroiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in Collaboration With the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical Carcinomas and Malignant Phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant Mitotane Treatment for Adrenocortical Carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1200\/JCO.2009.27.5958","article-title":"Adjuvant Therapy in Patients With Adrenocortical Carcinoma: A Position of an International Panel","volume":"28","author":"Berruti","year":"2010","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination Chemotherapy in Advanced Adrenocortical Carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-08-0237","article-title":"Microarray Gene Expression and Immunohistochemistry Analyses of Adrenocortical Tumors Identify IGF2 and Ki-67 as Useful in Differentiating Carcinomas From Adenomas","volume":"16","author":"Soon","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.23736\/S0391-1977.18.02882-1","article-title":"The Role of Insulin-Like Growth Factor System in the Adrenocortical Tumors","volume":"44","author":"Altieri","year":"2019","journal-title":"Minerva Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70081-1","article-title":"Linsitinib (OSI-906) Versus Placebo for Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma: A Double-Blind, Randomised, Phase 3 Study","volume":"16","author":"Fassnacht","year":"2015","journal-title":"Lancet Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-011-9502-1","article-title":"Significance of Heparanase-1 and Vascular Endothelial Growth Factor in Adrenocortical Carcinoma Angiogenesis: Potential for Therapy","volume":"40","author":"Xu","year":"2011","journal-title":"Endocrine"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0918","article-title":"Phase II Study of Weekly Paclitaxel and Sorafenib as Second\/Third-Line Therapy in Patients With Adrenocortical Carcinoma","volume":"166","author":"Berruti","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2011.00027","article-title":"Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma Cells","volume":"2","author":"Kroiss","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1419","article-title":"Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial","volume":"97","author":"Kroiss","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz318","article-title":"Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma With Cabozantinib","volume":"105","author":"Kroiss","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101434","article-title":"Next-Generation Therapies for Adrenocortical Carcinoma","volume":"34","author":"Altieri","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0659","article-title":"Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis","volume":"17","author":"Lieu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvq121","article-title":"Fibroblast Growth Factors: From Molecular Evolution to Roles in Development, Metabolism and Disease","volume":"149","author":"Itoh","year":"2011","journal-title":"J Biochem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/wdev.176","article-title":"The Fibroblast Growth Factor Signaling Pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.30.1819","article-title":"The Fgf Families in Humans, Mice, and Zebrafish: Their Evolutional Processes and Roles in Development, Metabolism, and Disease","volume":"30","author":"Itoh","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"B19","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ydbio.2005.09.011","article-title":"Functions and Regulations of Fibroblast Growth Factor Signaling During Embryonic Development","volume":"287","author":"Thisse","year":"2005","journal-title":"Dev Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-10-0168","article-title":"Roles of Fibroblast Growth Factor Receptors in Carcinogenesis","volume":"8","author":"Haugsten","year":"2010","journal-title":"Mol Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2780","article-title":"Fibroblast Growth Factor Signalling: From Development to Cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2174\/156800909789057006","article-title":"The Role of Fibroblast Growth Factors in Tumor Growth","volume":"9","author":"Korc","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S188316","article-title":"Lenvatinib, a Molecule With Versatile Application: From Preclinical Evidence to Future Development in Anti-Cancer Treatment","volume":"11","author":"Capozzi","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S189391","article-title":"Ponatinib: A Novel Multi-Tyrosine Kinase Inhibitor Against Human Malignancies","volume":"12","author":"Tan","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e001009","DOI":"10.1136\/jitc-2020-001009","article-title":"Combined Lenvatinib and Pembrolizumab as Salvage Therapy in Advanced Adrenal Cortical Carcinoma","volume":"8","author":"Bedrose","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/1878-0261.12194","article-title":"FGFR2 Amplification Is Predictive of Sensitivity to Regorafenib in Gastric and Colorectal Cancers In Vitro","volume":"12","author":"Cha","year":"2018","journal-title":"Mol Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1246","article-title":"High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial","volume":"6","author":"Pearson","year":"2016","journal-title":"Cancer Discov"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1810","article-title":"High FGFR1-4 mRNA Expression Levels Correlate With Response to Selective FGFR Inhibitors in Breast Cancer","author":"Sanchez-Guixe","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/endo-97-1-102","article-title":"Stimulation of Division of Y1 Adrenal Cells by a Growth Factor Isolated From Bovine Pituitary Glands","volume":"97","author":"Gospodarowicz","year":"1975","journal-title":"Endocrinology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/endo-100-4-1080","article-title":"Control of Bovine Adrenal Cortical Cell Proliferation by Fibroblast Growth Factor. Lack of Effect of Epidermal Growth Factor","volume":"100","author":"Gospodarowicz","year":"1977","journal-title":"Endocrinology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.9.7632","article-title":"Fibroblast Growth Factor-2 Inhibits the Maturation of Pro-Insulin-Like Growth Factor-II (Pro-IGF-II) and the Expression of Insulin-Like Growth Factor Binding Protein-2 (IGFBP-2) in the Human Adrenocortical Tumor Cell Line NCI-H295R","volume":"141","author":"Boulle","year":"2000","journal-title":"Endocrinology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-06-0083","article-title":"CITED2 is Expressed in Human Adrenocortical Cells and Regulated by Basic Fibroblast Growth Factor","volume":"192","author":"Haase","year":"2007","journal-title":"J Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/s0955-2235(05)80002-x","article-title":"Growth Factor Regulation of Adrenal Cortex Growth and Function","volume":"3","author":"Feige","year":"1991","journal-title":"Prog Growth Factor Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2013.01.014","article-title":"FGF Signalling Through Fgfr2 Isoform IIIb Regulates Adrenal Cortex Development","volume":"371","author":"Guasti","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13104-020-05110-5","article-title":"Subcellular Localization of Fibroblast Growth Factor Receptor Type 2 and Correlation With CTNNB1 Genotype in Adrenocortical Carcinoma","volume":"13","author":"Haase","year":"2020","journal-title":"BMC Res Notes"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01157-0","article-title":"Fibroblast Growth Factor Receptors in Cancer: Genetic Alterations, Diagnostics, Therapeutic Targets and Mechanisms of Resistance","volume":"124","author":"Krook","year":"2021","journal-title":"Br J Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12685","article-title":"Targeting Heterogeneity of Adrenocortical Carcinoma: Evaluation and Extension of Preclinical Tumor Models to Improve Clinical Translation","volume":"7","author":"Hantel","year":"2016","journal-title":"Oncotarget"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0447","article-title":"Development of New Preclinical Models to Advance Adrenocortical Carcinoma Research","volume":"25","author":"Kiseljak-Vassiliades","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.712107","article-title":"FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale","volume":"12","author":"Adam","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24030","article-title":"Limited Prognostic Value of the 2004 International Union Against Cancer Staging Classification for Adrenocortical Carcinoma: Proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3182","article-title":"Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3390\/cancers13071736","article-title":"Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues","volume":"13","author":"Sbiera","year":"2021","journal-title":"Cancers"},{"key":"B44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.bi.58.070189.003043","article-title":"The Heparin-Binding (Fibroblast) Growth Factor Family of Proteins","volume":"58","author":"Burgess","year":"1989","journal-title":"Annu Rev Biochem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.153.4.811","article-title":"Fibroblast Growth Factor Signaling and Basement Membrane Assembly are Connected During Epithelial Morphogenesis of the Embryoid Body","volume":"153","author":"Li","year":"2001","journal-title":"J Cell Biol"},{"key":"B46","article-title":"Loss of the Tumorigenic Phenotype With In Vitro, But Not In Vivo, Passaging of a Novel Series of Human Bronchial Epithelial Cell Lines: Possible Role of an Alpha 5\/Beta 1-Integrin-Fibronectin Interaction","volume":"55","author":"Schiller","year":"1995","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/en.2014-1159","article-title":"Phospholipase D Activity Underlies Very-Low-Density Lipoprotein (VLDL)-Induced Aldosterone Production in Adrenal Glomerulosa Cells","volume":"155","author":"Tsai","year":"2014","journal-title":"Endocrinology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mce.2004.05.006","article-title":"Angiotensin II-Stimulated Cortisol Secretion is Mediated by Phospholipase D","volume":"222","author":"Rabano","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00097.2004","article-title":"Angiotensin II Early Regulated Genes in H295R Human Adrenocortical Cells","volume":"19","author":"Romero","year":"2004","journal-title":"Physiol Genomics"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2015.06.022","article-title":"Fgfr2 Is Required for the Expansion of the Early Adrenocortical Primordium","volume":"413","author":"Hafner","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41467-020-15332-7","article-title":"Beta-Catenin and FGFR2 Regulate Postnatal Rosette-Based Adrenocortical Morphogenesis","volume":"11","author":"Leng","year":"2020","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/en.2012-1892","article-title":"Conditional Mutagenesis of Gata6 in SF1-Positive Cells Causes Gonadal-Like Differentiation in the Adrenal Cortex of Mice","volume":"154","author":"Pihlajoki","year":"2013","journal-title":"Endocrinology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0068","article-title":"Transcriptional Profiling Enables Molecular Classification of Adrenocortical Tumours","volume":"161","author":"Laurell","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2165","article-title":"Molecular Screening for a Personalized Treatment Approach in Advanced Adrenocortical Cancer","volume":"98","author":"De Martino","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-11-0231","article-title":"The Role of Fibroblast Growth Factor Receptor 4 Overexpression and Gene Amplification as Prognostic Markers in Pediatric and Adult Adrenocortical Tumors","volume":"19","author":"Brito","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ndt\/gfy126","article-title":"Klotho and Endocrine Fibroblast Growth Factors: Markers of Chronic Kidney Disease Progression and Cardiovascular Complications","volume":"34","author":"Kuro","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/s0925-4773(00)00427-5","article-title":"Tissue-Specific Expression of GTPas RalA and RalB During Embryogenesis and Regulation by Epithelial-Mesenchymal Interaction","volume":"97","author":"Zhao","year":"2000","journal-title":"Mech Dev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17507","article-title":"Alternative Promotion and Suppression of Metastasis by JNK2 Governed by its Phosphorylation","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgx032","article-title":"Inactivation of JNK2 as Carcinogenic Factor in Colitis-Associated and Sporadic Colorectal Carcinogenesis","volume":"38","author":"Lessel","year":"2017","journal-title":"Carcinogenesis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/srep08997","article-title":"PIK3R1 Negatively Regulates the Epithelial-Mesenchymal Transition and Stem-Like Phenotype of Renal Cancer Cells Through the AKT\/GSK3beta\/CTNNB1 Signaling Pathway","volume":"5","author":"Lin","year":"2015","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3390\/cancers11081154","article-title":"Association Between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer","volume":"11","author":"Kang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2019.03.015","article-title":"Serum Biomarkers for Predicting Overall Survival and Early Mortality in Older Patients With Metastatic Solid Tumors","volume":"10","author":"Kim","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2009.01105.x","article-title":"Hypoxia and Low-Nutrition Double Stress Induces Aggressiveness in a Murine Model of Melanoma","volume":"100","author":"Osawa","year":"2009","journal-title":"Cancer Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1800973","DOI":"10.1183\/13993003.00973-2018","article-title":"Fibroblast Growth Factor 21 Predicts Outcome in Community-Acquired Pneumonia: Secondary Analysis of Two Randomised Controlled Trials","volume":"53","author":"Ebrahimi","year":"2019","journal-title":"Eur Respir J"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30412-7","article-title":"Rogaratinib in Patients With Advanced Cancers Selected by FGFR mRNA Expression: A Phase 1 Dose-Escalation and Dose-Expansion Study","volume":"20","author":"Schuler","year":"2019","journal-title":"Lancet Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32224","article-title":"Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-Overexpressing Preclinical Cancer Models","volume":"145","author":"Grunewald","year":"2019","journal-title":"Int J Cancer"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.795116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T10:49:46Z","timestamp":1639046986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.795116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":66,"alternative-id":["10.3389\/fendo.2021.795116"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.795116","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,9]]},"article-number":"795116"}}